Originally published on Wed April 23, 2014 7:46 am
People who qualified for subsidies under the Affordable Care Act aren't necessarily locked into the plan they chose. And that can be good news for people whose income fluctuates during the year. Here's our response to the latest reader questions on coverage through the health exchanges.
INSKEEP: Actually, it's cat cafe. There's been a bit of a cat fight over which city would host the nation's first cat cafe, meaning a place where patrons can cozy up with a latte and also a feline in need of a good home and hopefully adopt that cat.
NPR's business news starts with the rising cost of Netflix.
(SOUNDBITE OF MUSIC)
MONTAGNE: The online video provider will raise the price of its subscriptions by one or two dollars over the next few months. This only affects new subscribers for now. Current subscribers won't see a rate hike for at least a year.
CEO Reed Hastings says the higher fees will increase the number of TV shows and movies Netflix offers and improve video streaming. Transcript provided by NPR, Copyright NPR.
Bruce Springsteen may have been ahead of his times with his song "57 Channels (And Nothin' On)," released in 1992. These days there are hundreds of channels, and whether you like it or not, you get most of them in your basic cable package. On Tuesday, that economic model is being challenged in the Supreme Court in a high-stakes legal battle between the broadcast television networks and a tiny startup, or at least tiny by broadcast standards.
The issues focus on copyright law, but the outcome could alter the face of broadcasting in the United States.
Two important cases will be argued before the U.S. Supreme Court today. One of them involves a high-stakes, high-tech battle that has raised the possibility of major TV networks no longer broadcasting over the air. The other case involves the future of lying in political campaigns. Here's NPR's legal affairs correspondent Nina Totenberg.
The Food and Drug Administration is trying to decide whether to approve a powerful new prescription painkiller that's designed to relieve severe pain quickly, and with fewer side effects than other opioids.
While some pain experts say the medicine could provide a valuable alternative for some patients in intense pain, the drug (called Moxduo) is also prompting concern that it could exacerbate the epidemic of abuse of prescription painkillers and overdoses.